Literature DB >> 7973217

The what, why and how of Bayesian clinical trials monitoring.

L S Freedman1, D J Spiegelhalter, M K Parmar.   

Abstract

We discuss the advantages and limitations of group sequential methods for monitoring clinical trials data. We describe a Bayesian approach, based upon the use of sceptical prior distributions, that avoids some of the limitations of group sequential methods. We illustrate its use with data from a trial of levamisole plus 5-Fluorouracil for colorectal cancer.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7973217     DOI： 10.1002/sim.4780131312

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  12 in total

Review 1.  Methods in health service research. An introduction to bayesian methods in health technology assessment.

Authors:  D J Spiegelhalter; J P Myles; D R Jones; K R Abrams
Journal:  BMJ       Date:  1999-08-21

Review 2.  Trials and fast changing technologies: the case for tracker studies.

Authors:  R J Lilford; D A Braunholtz; R Greenhalgh; S J Edwards
Journal:  BMJ       Date:  2000-01-01

Review 3.  Strategy for randomised clinical trials in rare cancers.

Authors:  Say-Beng Tan; Keith B G Dear; Paolo Bruzzi; David Machin
Journal:  BMJ       Date:  2003-07-05

4.  Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Authors:  Rebecca A Miksad; Mithat Gönen; Thomas J Lynch; Thomas G Roberts
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

5.  Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints.

Authors:  Zhenning Yu; Viswanathan Ramakrishnan; Caitlyn Meinzer
Journal:  J Biopharm Stat       Date:  2019-02-14       Impact factor: 1.051

6.  Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.

Authors:  Rebecca S Slack Tidwell; S Andrew Peng; Minxing Chen; Diane D Liu; Ying Yuan; J Jack Lee
Journal:  Clin Trials       Date:  2019-08-26       Impact factor: 2.486

7.  Neural dynamics differentially encode phrases and sentences during spoken language comprehension.

Authors:  Fan Bai; Antje S Meyer; Andrea E Martin
Journal:  PLoS Biol       Date:  2022-07-14       Impact factor: 9.593

Review 8.  Interim analysis: A rational approach of decision making in clinical trial.

Authors:  Amal Kumar; Bhaswat S Chakraborty
Journal:  J Adv Pharm Technol Res       Date:  2016 Oct-Dec

9.  Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: a survey from the Italian National Monitoring Centre for Clinical Trials.

Authors:  Irene Floriani; Nicole Rotmensz; Elena Albertazzi; Valter Torri; Marisa De Rosa; Carlo Tomino; Fillipo de Braud
Journal:  Trials       Date:  2008-07-25       Impact factor: 2.279

10.  Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study.

Authors:  Md Badrul Islam; Zhahirul Islam; Shafiqur Rahman; Hubert P Endtz; Margreet C Vos; Mathieu van der Jagt; Pieter A van Doorn; Bart C Jacobs; Quazi D Mohammad
Journal:  Pilot Feasibility Stud       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.